The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive genomic sequencing for triple negative breast cancer in Japan.
 
Masayuki Nagahashi
No Relationships to Disclose
 
Tetsu Hayashida
No Relationships to Disclose
 
Yuko Kitagawa
Honoraria - Chugai Pharma; Ethicon; Nippon Kayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ajinomoto (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); GlaxoSmithKline (Inst); Kaken Pharmaceutical (Inst); Kowa (Inst); Kureha (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Medtronic (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Novartis (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Taisho Toyama Pharma (Inst); Takeda (Inst); Teijin Pharma (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Manabu Futamura
No Relationships to Disclose
 
Kazuhiro Yoshida
Honoraria - Chugai Pharma; Daiichi Sankyo; EA Pharma; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); EA Pharma (Inst); Lilly Japan (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
Travel, Accommodations, Expenses - Chugai Pharma; Daiichi Sankyo; EA Pharma; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Takashi Kuwayama
No Relationships to Disclose
 
Seigo Nakamura
No Relationships to Disclose
 
Chie Toshikawa
No Relationships to Disclose
 
Hideko Yamauchi
Honoraria - AstraZeneca; Taiho Pharmaceutical
 
Koji Kaneko
No Relationships to Disclose
 
Nobuaki Sato
No Relationships to Disclose
 
Junko Tsuchida
No Relationships to Disclose
 
Kizuki Yuza
No Relationships to Disclose
 
Yoshifumi Shimada
No Relationships to Disclose
 
Hiroshi Ichikawa
No Relationships to Disclose
 
Jennifer E. Ring
Employment - KEW
Stock and Other Ownership Interests - KEW
 
Stephen Lyle
Employment - KEW
Stock and Other Ownership Interests - KEW
 
Shujiro Okuda
No Relationships to Disclose
 
Kazuaki Takabe
No Relationships to Disclose
 
Toshifumi Wakai
Research Funding - Denka Co., Ltd (Inst)